Corteva (CTVA) to Release Quarterly Earnings on Thursday

Corteva (NYSE:CTVA) is expected to be posting its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Corteva to post earnings of $2.24 per share and revenue of $6.5993 billion for the quarter. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, July 31, 2026 at 9:00 AM ET.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the company posted $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. On average, analysts expect Corteva to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Corteva Price Performance

Shares of NYSE CTVA opened at $88.98 on Wednesday. The company has a market capitalization of $59.51 billion, a PE ratio of 52.34, a P/E/G ratio of 2.65 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva has a twelve month low of $60.53 and a twelve month high of $89.75. The firm has a fifty day simple moving average of $81.72 and a 200 day simple moving average of $79.26.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Hedge Funds Weigh In On Corteva

Several institutional investors have recently made changes to their positions in the stock. Invesco Ltd. raised its stake in Corteva by 16.7% during the 4th quarter. Invesco Ltd. now owns 11,404,960 shares of the company’s stock worth $764,474,000 after buying an additional 1,630,712 shares during the period. Axxcess Wealth Management LLC grew its stake in Corteva by 1.2% in the fourth quarter. Axxcess Wealth Management LLC now owns 31,120 shares of the company’s stock valued at $2,086,000 after acquiring an additional 355 shares during the period. Corient Private Wealth LLC grew its stake in Corteva by 4.8% in the fourth quarter. Corient Private Wealth LLC now owns 203,950 shares of the company’s stock valued at $13,422,000 after acquiring an additional 9,388 shares during the period. Ameriflex Group Inc. increased its holdings in shares of Corteva by 14,875.0% during the fourth quarter. Ameriflex Group Inc. now owns 599 shares of the company’s stock valued at $40,000 after acquiring an additional 595 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its holdings in shares of Corteva by 3.8% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 71,499 shares of the company’s stock valued at $4,793,000 after acquiring an additional 2,620 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CTVA shares. UBS Group lowered their price objective on Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research report on Tuesday, June 9th. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. The Goldman Sachs Group raised their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Rothschild & Co Redburn raised their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Finally, CICC Research lifted their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus price target of $90.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.